Abstract:The aim of this study was to investigate the prokaryotic expression of antimicrobial peptide cathelicidin (CATH) PR1 and PR2 from the skin of Paa robertingeri in Escherichia coli. Two active peptides, CATH PR1 and CATH PR2, belong to the CATH family in the skin of P. robertingeri. CATH PR1 has a relatively high antimicrobial activity, especially for the drug-resistant strains found in clinical practice; however, no antimicrobial activity has been found in CATH PR2. The molecular weights of both CATH PR1 and CATH PR2 are relatively low (3195.88 and 2838.34 Da, respectively). Thus, the genetic processes, as well as the expression and purification of these proteins, are difficult to perform. Therefore, in this study, CATH PR1 and CATH PR2 genes were tandem ligated and then connected to the plasmid pET-32a. This reconstructed plasmid was then transfected into the expression vector E. coli BL21 to construct the recombinant expression system. The fusion expression of peptide PR was stable in E. coli after induction with 1.0 mol/L isopropyl beta-D-1-thiogalactopyranoside at 37 degrees C for 4 h. The antimicrobial activity assay using Staphylococcus aureus (Song) and Candida albicans 08030102 showed that the antimicrobial activity of PR was similar to the antimicrobial activity of CATH PR1. This study showed that artificial modification of the amino acid sequences of PR1 and PR2 could result in better protein expression in prokaryotes, and the fusion protein expressed had relatively high antimicrobial and other biological activities. In conclusion, the findings suggest future prospects of the commercialization of this method.

Expression and Purification of Two Different Antimicrobial Peptides, PR-39 and Protegrin-1 in Escherichia Coli.

Fusion expression of protegrin-1 gene from swine in Escherichia coli.

Recombinant Secretory Expression, Purification and Antimicrobial Activity of Pr39 in Bacillus Subtilis Using A Maltose-Inducible Vector

Prokaryotic Expression and Functional Verification of Antimicrobial Peptide LRGG

[Fusion Expression of Antimicrobial Peptides in Escherichia Coli].

Expression of Hybrid Peptide EF-1 in Pichia pastoris, Its Purification, and Antimicrobial Characterization

Recombinant Expression of Antimicrobial Peptides Using a Novel Self-Cleaving Aggregation Tag Inescherichia Coli

High-level Expression,Purification and Activity of the Plectasin

Fusion Expression of Antimicrobial Peptide GK1 in Escherichia Coli

Biological Characteristics of the Antibacterial Peptide PR39 Expressed in Escherichia Coli

Prokaryotic Expression of Antimicrobial Peptide CATH PR1-2 from the Skin of Paa robertingeri in Escherichia coli

Recombinant expression of a novel antimicrobial peptide consisting of human α-defensin 5 and Mytilus coruscus mytilin-1 in Escherichia coli

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Expression and Purification of Antimicrobial Peptide AP2 Using SUMO Fusion Partner Technology Inescherichia Coli

A Eukaryotic Expression Strategy for Producing the Novel Antimicrobial Peptide PRW4

[Secreted Expression of the Combinant Antimicrobial Peptide PL in Pichia Pastoris and Its Antibacterial Activity in Vitro].

High-Level Production of a Novel Antimicrobial Peptide Perinerin in Escherichia Coli by Fusion Expression

The Fusion Expression of a Novel Antimicrobial Peptide Perinerin in Escherichia Coli

Expression and Purification of an Antimicrobial Peptide, Bovine Lactoferricin Derivative LfcinB-W10 in Escherichia Coli

Heterologous expression of the novel α-helical hybrid peptide PR-FO in Bacillus subtilis

Expression of a Cytotoxic Cationic Antibacterial Peptide in Escherichia Coli Using Two Fusion Partners